{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T07:20:53Z","timestamp":1772004053549,"version":"3.50.1"},"reference-count":49,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Drug Policy"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.drugpo.2018.12.015","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T10:20:56Z","timestamp":1550917256000},"page":"9-18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["The projected costs and benefits of a supervised injection facility in Seattle, WA, USA"],"prefix":"10.1016","volume":"67","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2671-3442","authenticated-orcid":false,"given":"J.E.","family":"Hood","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3885-088X","authenticated-orcid":false,"given":"C.N.","family":"Behrends","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Irwin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.R.","family":"Schackman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Hartfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Hess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Banta-Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Whiteside","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Finegood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Duchin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.drugpo.2018.12.015_bib0005","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.drugpo.2009.03.004","article-title":"A cost-benefit and cost-effectiveness analysis of Vancouver\u2019s supervised injection facility","volume":"21","author":"Andresen","year":"2010","journal-title":"The International Journal of Drug Policy"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0010","series-title":"National vital statistics reports","article-title":"United States life tables","author":"Arias","year":"2014"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0015","series-title":"Illicit drug overdose deaths in BC, January 1, 2008- November 30, 2018","author":"British Columbia Coroners Service","year":"2018"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0020","series-title":"Annual surveillance report of drug-related risks and outcomes \u2014 United States, 2017. Surveillance special report 1. Centers for disease control and prevention","author":"Centers for Disease Control and Prevention","year":"2017"},{"issue":"16","key":"10.1016\/j.drugpo.2018.12.015_bib0025","first-page":"443","article-title":"Community outbreak of HIV infection linked to injection drug use of oxymorphone--Indiana, 2015","volume":"64","author":"Conrad","year":"2015","journal-title":"MMWR Morbidity and Mortality Weekly Report"},{"issue":"8","key":"10.1016\/j.drugpo.2018.12.015_bib0030","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1046\/j.1360-0443.2003.00474.x","article-title":"The ratio of non-fatal to fatal heroin overdose","volume":"98","author":"Darke","year":"2003","journal-title":"Addiction"},{"issue":"2-3","key":"10.1016\/j.drugpo.2018.12.015_bib0035","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.drugalcdep.2010.07.023","article-title":"Injection drug use cessation and use of North America\u2019s first medically supervised safer injecting facility","volume":"113","author":"DeBeck","year":"2011","journal-title":"Drug and Alcohol Dependence"},{"issue":"1","key":"10.1016\/j.drugpo.2018.12.015_bib0040","doi-asserted-by":"crossref","first-page":"55","DOI":"10.3109\/00952990.2011.600389","article-title":"The validity of reporting willingness to use a supervised injecting facility on subsequent program use among people who use injection drugs","volume":"38","author":"DeBeck","year":"2012","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0045","unstructured":"Department of Commerce (2016). Personal income summary: Personal income, population, per capita personal income, King County. Retrieved from. https:\/\/www.bea.gov\/itable\/index.cfm."},{"key":"10.1016\/j.drugpo.2018.12.015_bib0050","series-title":"CMS manual: Pub 100-04 medicare claims processing","author":"DHHS","year":"2015"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0055","series-title":"The country\u2019s first safe injection facility may soon open in Philadelphia. Here\u2019s What you need to know","author":"Ducharme","year":"2018"},{"issue":"3","key":"10.1016\/j.drugpo.2018.12.015_bib0060","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/add.13195","article-title":"Potential cost-effectiveness of supervised injection facilities in Toronto and Ottawa, Canada","volume":"111","author":"Enns","year":"2016","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0065","first-page":"p. 51","article-title":"Highlights from the 2015 Seattle area national HIV behavioral surveillance survey of injection drug use","volume":"Vol, 85","author":"Glick","year":"2016"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0070","unstructured":"Heroin and Prescription Opiate Addiction Task Force Final Report and Recommendations (2016). Retrieved from https:\/\/www.kingcounty.gov\/\u223c\/media\/depts\/community-human-services\/behavioral-health\/documents\/herointf\/Final-Heroin-Opiate-Addiction-Task-_Force-Report.ashx?la=en."},{"key":"10.1016\/j.drugpo.2018.12.015_bib0075","article-title":"Public health \u2013 Seattle & King County and the infectious disease assessment unit","volume":"Vol. 86","author":"HIV\/AIDS Epidemiology Unit","year":"2017"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0080","series-title":"Emergency room services \u2013 Facility coding guidelines","author":"HMSA","year":"2016"},{"issue":"2","key":"10.1016\/j.drugpo.2018.12.015_bib0085","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/0022042616679829","article-title":"A cost-benefit analysis of a potential supervised injection facility in San Francisco, California, USA","volume":"47","author":"Irwin","year":"2017","journal-title":"Journal of Drug Issues"},{"issue":"1","key":"10.1016\/j.drugpo.2018.12.015_bib0090","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12954-017-0153-2","article-title":"Mitigating the heroin crisis in Baltimore, MD, USA: A cost-benefit analysis of a hypothetical supervised injection facility","volume":"14","author":"Irwin","year":"2017","journal-title":"Harm Reduction Journal"},{"issue":"1","key":"10.1016\/j.drugpo.2018.12.015_bib0095","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11524-010-9525-6","article-title":"Risk factors for nonfatal overdose at Seattle-area syringe exchanges","volume":"88","author":"Jenkins","year":"2011","journal-title":"Journal of Urban Health"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0100","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.2747\/0272-3638.33.8.1144","article-title":"A little heaven in hell\": The role of a supervised injection facility in transforming place","volume":"33","author":"Jozaghi","year":"2012","journal-title":"Urban Geography"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0105","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1747-597X-8-25","article-title":"A cost-benefit\/cost-effectiveness analysis of proposed supervised injection facilities in Montreal, Canada","volume":"8","author":"Jozaghi","year":"2013","journal-title":"Substance Abuse Treatment, Prevention, and Policy"},{"issue":"9482","key":"10.1016\/j.drugpo.2018.12.015_bib0110","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1016\/S0140-6736(05)66475-6","article-title":"Safer injection facility use and syringe sharing in injection drug users","volume":"366","author":"Kerr","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0115","series-title":"Hepatitis C","author":"King County","year":"2018"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0120","series-title":"Overdose deaths","author":"King County Medical Examiner Office","year":"2018"},{"issue":"3","key":"10.1016\/j.drugpo.2018.12.015_bib0125","doi-asserted-by":"crossref","first-page":"482","DOI":"10.2105\/AJPH.2013.301601","article-title":"Estimating acute viral hepatitis infections from nationally reported cases","volume":"104","author":"Klevens","year":"2014","journal-title":"American Journal of Public Health"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0130","series-title":"Needle Exchange Client Surveys 2011, 2013, and 2015: Drugs used, risk and protective behaviors, overdose, health insurance coverage, and health concern","author":"Kummer","year":"2015"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0135","series-title":"Supervised consumption facilities: Review of the evidence","author":"Larson","year":"2017"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0140","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1186\/1471-2458-8-405","article-title":"Risk factors for developing a cutaneous injection-related infection among injection drug users: A cohort study","volume":"8","author":"Lloyd-Smith","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0145","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1186\/1471-2458-10-327","article-title":"Determinants of hospitalization for a cutaneous injection-related infection among injection drug users: A cohort study","volume":"10","author":"Lloyd-Smith","year":"2010","journal-title":"BMC Public Health"},{"issue":"2","key":"10.1016\/j.drugpo.2018.12.015_bib0150","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2471\/BLT.12.108282","article-title":"Mortality among people who inject drugs: A systematic review and meta-analysis","volume":"91","author":"Mathers","year":"2013","journal-title":"Bulletin of the World Health Organization"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0155","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.drugpo.2018.06.018","article-title":"The impact of medically supervised injection centres on drug-related harms: A meta-analysis","volume":"59","author":"May","year":"2018","journal-title":"The International Journal of Drug Policy"},{"issue":"3","key":"10.1016\/j.drugpo.2018.12.015_bib0160","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.drugalcdep.2010.04.018","article-title":"Methadone maintenance and the cost and utilization of health care among individuals dependent on opioids in a commercial health plan","volume":"111","author":"McCarty","year":"2010","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0165","series-title":"No one values your life more than the federal government","author":"Merrill","year":"2017"},{"issue":"4","key":"10.1016\/j.drugpo.2018.12.015_bib0170","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1080\/00952990802122457","article-title":"Non-fatal overdose among a cohort of active injection drug users recruited from a supervised injection facility","volume":"34","author":"Milloy","year":"2008","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0175","series-title":"Final report of the evaluation of the Sydney medically supervised injecting centre","author":"MSIC Evaluation Committee","year":"2003"},{"issue":"9","key":"10.1016\/j.drugpo.2018.12.015_bib0180","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s40273-016-0400-5","article-title":"Economic evaluations of opioid use disorder interventions","volume":"34","author":"Murphy","year":"2016","journal-title":"Pharmacoeconomics"},{"issue":"8","key":"10.1016\/j.drugpo.2018.12.015_bib0185","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1046\/j.1360-0443.2003.00476.x","article-title":"The ratio of non-fatal to fatal heroin overdose","volume":"98","author":"Neale","year":"2003","journal-title":"Addiction"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0190","series-title":"Methadone treatment for opiate addiction lowers health care costs and reduces arrests and convictions","author":"Nordlund","year":"2004"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0195","series-title":"Population","author":"Office of Financial Management","year":"2017"},{"issue":"3","key":"10.1016\/j.drugpo.2018.12.015_bib0200","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.drugpo.2011.03.003","article-title":"How many HIV infections are prevented by Vancouver Canada\u2019s supervised injection facility?","volume":"22","author":"Pinkerton","year":"2011","journal-title":"The International Journal of Drug Policy"},{"issue":"6","key":"10.1016\/j.drugpo.2018.12.015_bib0205","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.jval.2012.06.011","article-title":"Dynamic transmission modeling: A report of the ISPOR-SMDM modeling good research practices task force--5","volume":"15","author":"Pitman","year":"2012","journal-title":"Value in Health"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0210","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.drugalcdep.2014.10.012","article-title":"Supervised injection services: What has been demonstrated? A systematic literature review","volume":"145","author":"Potier","year":"2014","journal-title":"Drug and Alcohol Dependence"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0215","doi-asserted-by":"crossref","first-page":"j1550","DOI":"10.1136\/bmj.j1550","article-title":"Mortality risk during and after opioid substitution treatment: Systematic review and meta-analysis of cohort studies","volume":"357","author":"Sordo","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0220","series-title":"Updated population estimates for men who have sex with men (MSM) and people who inject drugs (PWID) estimates for King County","author":"Thiede","year":"2014"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0225","unstructured":"Vancouver Coastal Health (2015). Insite user statistics. Retrieved from. http:\/\/www.vch.ca\/Documents\/Insite-user-statistics-2015.pdf."},{"key":"10.1016\/j.drugpo.2018.12.015_bib0230","unstructured":"Vancouver Coastal Health (2016). Insite user statistics. Retrieved from. http:\/\/www.vch.ca\/Documents\/Insite-user-statistics-2016.pdf."},{"key":"10.1016\/j.drugpo.2018.12.015_bib0235","unstructured":"Vancouver Coastal Health (2017). Insite \u2013 Supervised injection site. Retrieved from. http:\/\/www.vch.ca\/Locations-Services\/result?res_id=964."},{"key":"10.1016\/j.drugpo.2018.12.015_bib0240","series-title":"Insite \u2013 supervised injection site","author":"Vancouver Coastal Health","year":"2018"},{"key":"10.1016\/j.drugpo.2018.12.015_bib0245","series-title":"Charity care in Washington hospitals","author":"Washington Department of Health","year":"2017"}],"container-title":["International Journal of Drug Policy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919300027?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0955395919300027?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T15:43:06Z","timestamp":1760629386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0955395919300027"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":49,"alternative-id":["S0955395919300027"],"URL":"https:\/\/doi.org\/10.1016\/j.drugpo.2018.12.015","relation":{},"ISSN":["0955-3959"],"issn-type":[{"value":"0955-3959","type":"print"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The projected costs and benefits of a supervised injection facility in Seattle, WA, USA","name":"articletitle","label":"Article Title"},{"value":"International Journal of Drug Policy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.drugpo.2018.12.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}